文献速递产科母胎医学

妊娠期糖尿病与妊娠期高血压疾病同时发生对胎儿生长和新生儿发病率的影响

The simultaneous occurrence of gestational diabetes and hypertensive disorders of pregnancy affects fetal growth and neonatal morbidity.
PubMed 文献 · Am J Obstet Gynecol · 2024-03-14

一项回顾性研究纳入47,093例单胎妊娠,比较妊娠期糖尿病(GDM) alone、妊娠期高血压疾病(HDP) alone及两者共存与无两者对照的胎儿生长和新生儿结局。结果显示GDM/HDP共存者适于胎龄儿出生体重几率降低(aOR 0.72),新生儿发病率复合结局风险显著升高(aOR 3.13),且高于任一单独疾病。

要点

  • GDM/HDP共存者适于胎龄儿出生体重的aOR为0.72(95%CI 0.52-1.00,P=.049),低于无两者者。
  • GDM/HDP共存者新生儿发病率复合结局aOR为3.13(95%CI 2.35-4.17,P<.001),高于GDM alone(aOR 2.01)和HDP alone(aOR 1.38)。
  • GDM/HDP共存者大于胎龄儿和小于胎龄儿的调整关联均未达统计学显著(aOR分别为1.33和1.32)。

核心结论

  • GDM/HDP共存妊娠的出生体重百分位数中位数与无两者妊娠相似,但异常胎儿生长和新生儿发病风险更高。

研究设计与样本

  • 回顾性研究纳入47,093例单胎妊娠,采用广义估计方程比较GDM alone、HDP alone及GDM/HDP共存与无两者妊娠的适于胎龄儿出生体重发生率,校正母亲年龄、初产、体重指数、保险类型、种族、婚姻状态和产前保健地点。

主要发现

  • GDM/HDP共存者适于胎龄儿出生体重率78.2% vs 无两者者84.9%,调整后aOR 0.72(95%CI 0.52-1.00,P=.049);GDM alone aOR 0.78(0.68-0.89,P<.001);HDP alone aOR 0.73(0.66-0.81,P<.001)。
  • GDM/HDP共存者大于胎龄儿绝对风险14.5% vs 无两者者8.2%,调整后aOR 1.33(95%CI 0.88-2.00,P=.171)未达统计学显著;小于胎龄儿7.3% vs 6.9%,调整后aOR 1.32(0.80-2.19,P=.293)未达统计学显著。
  • 新生儿发病率复合结局:GDM/HDP共存aOR 3.13(95%CI 2.35-4.17,P<.001),GDM alone aOR 2.01(1.78-2.27,P<.001),HDP alone aOR 1.38(1.26-1.50,P<.001)。
  • GDM/HDP共存者出生体重百分位数中位数(四分位距)为50(24.0-78.0)(N=179),无两者者为50(27.0-73.0)(N=35,833)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Gestational diabetes is associated with increased risk of hypertensive disorders of pregnancy, but there are limited data on fetal growth and neonatal outcomes when both conditions are present. OBJECTIVE: We evaluated the risk of abnormal fetal growth and neonatal morbidity in pregnancies with co-occurrence of gestational diabetes and hypertensive disorders of pregnancy. STUDY DESIGN: In a retrospective study of 47,093 singleton pregnancies, we compared the incidence of appropriate for gestational age birthweight in pregnancies affected by gestational diabetes alone, hypertensive disorders of pregnancy alone, or both gestational diabetes and hypertensive disorders of pregnancy with that in pregnancies affected by neither disorder using generalized estimating equations (covariates: maternal age, nulliparity, body mass index, insurance type, race, marital status, and prenatal care site). Secondary outcomes were large for gestational age birthweight, small for gestational age birthweight, and a neonatal morbidity composite outcome (stillbirth, hypoglycemia, hyperbilirubinemia, respiratory distress, encephalopathy, preterm delivery, neonatal death, and neonatal intensive care unit admission). RESULTS: The median (interquartile range) birthweight percentile in pregnancies with both gestational diabetes and hypertensive disorders of pregnancy (50 [24.0-78.0]; N=179) was similar to that of unaffected pregnancies (50 [27.0-73.0]; N=35,833). However, the absolute rate of appropriate for gestational age birthweight was lower for gestational diabetes/hypertensive disorders of pregnancy co-occurrence (78.2% vs 84.9% for unaffected pregnancies). Adjusted analyses showed decreased odds of appropriate for gestational age birthweight in pregnancies with both gestational diabetes and hypertensive disorders of pregnancy compared with unaffected pregnancies (adjusted odds ratio, 0.72 [95% confidence interval, 0.52-1.00]; P=.049), and in pregnancies complicated by gestational diabetes alone (adjusted odds ratio, 0.78 [0.68-0.89]; P<.001) or hypertensive disorders of pregnancy alone (adjusted odds ratio, 0.73 [0.66-0.81]; P<.001). The absolute risk of large for gestational age birthweight was greater in pregnancies with both gestational diabetes and hypertensive disorders of pregnancy (14.5%) than in unaffected pregnancies (8.2%), without apparent difference in the risk of small for gestational age birthweight (7.3% vs 6.9%). However, in adjusted models comparing pregnancies with gestational diabetes/hypertensive disorders of pregnancy co-occurrence with unaffected pregnancies, neither an association with large for gestational age birthweight (adjusted odds ratio, 1.33 [0.88-2.00]; P=.171) nor small for gestational age birthweight (adjusted odds ratio, 1.32 [0.80-2.19]; P=.293) reached statistical significance. Gestational diabetes/hypertensive disorders of pregnancy co-occurrence carried an increased risk of neonatal morbidity that was greater than that observed with either condition alone (gestational diabetes/hypertensive disorders of pregnancy: adjusted odds ratio, 3.13 [2.35-4.17]; P<.001; gestational diabetes alone: adjusted odds ratio, 2.01 [1.78-2.27]; P<.001; hypertensive disorders of pregnancy alone: adjusted odds ratio, 1.38 [1.26-1.50]; P<.001). CONCLUSION: Although pregnancies with both gestational diabetes and hypertensive disorders of pregnancy have a similar median birthweight percentile to those affected by neither condition, pregnancies concurrently affected by both conditions have a higher risk of abnormal fetal growth and neonatal morbidity.

来源:Am J Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Onuoha C, Schulte CCM, Thaweethai T, et al. The simultaneous occurrence of gestational diabetes and hypertensive disorders of pregnancy affects fetal growth and neonatal morbidity. Am J Obstet Gynecol. 2024. PMID: 38492713. doi:10.1016/j.ajog.2024.03.009

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。